Aquilo Capital Management, LLC
SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2020-02-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUILO CAPITAL MANAGEMENT, LLC (US)
- Others nearbySan Francisco, CA
$147.3m
reported value
11positions
99.9%in top 10
—no comparable previous quarter
Options: 0 call positions (— notional), 1 put positions ($118.9m notional) – listed below, not included above.
Holdings, Q4 2019
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| UNIQURE NV QURE | $28.4m19.30% | — |
| PROQR THRAPEUTICS N V PRQR | $19.1m12.93% | — |
| PIERIS PHARMACEUTICALS INC COM | $17.8m12.06% | — |
| XENON PHARMACEUTICALS INC XENE | $15.3m10.38% | — |
| GALAPAGOS NV LKFT | $14.9m10.10% | — |
| MERUS N V MRUS | $14.6m9.93% | — |
| DICERNA PHARMACEUTICALS INC DRNA | $13.5m9.19% | — |
| SPERO THERAPEUTICS INC SPRO | $11.1m7.53% | — |
| REGENXBIO INC RGNX | $11.0m7.47% | — |
| FATE THERAPEUTICS INC FATE | $1.4m0.96% | — |
| MORPHOSYS AG SPONSORED ADS | $217.0k0.15% | — |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR SER TR XBI · Put | $118.9m1.2m shares | — |